JAC Advance Access originally published online on February 25, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 843-847
© 2003 The British Society for Antimicrobial Chemotherapy
In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides
1 Institute of Infectious Diseases and Public Health, University of Ancona; 2 Department of Biomedical Sciences and Technology, University of Udine; 3 National Laboratory CIB, Area Science Park, Padriciano 99, 34012 Trieste, Italy
Received 7 June 2002; returned 26 June 2002; revised 22 October 2002; accepted 13 January 2003
Two laboratory methods, a cell culture system and double fluorogenic staining, were used to study the viability and infective ability of Cryptosporidium parvum sporozoites and oocysts after short-term exposure to four cathelicidin peptides. The compounds, SMAP-29, BMAP-28, PG-1 and Bac7(1-35), exerted a strong cytotoxic effect on sporozoites, but did not affect the viability and function of oocysts consistently. Overall, in the sporozoite series, a percentage of the viable population decreased rapidly to less than detectable levels after 15 and 60 min exposure to the peptides at concentrations of 100 and 10 µg/mL, respectively. In the oocyst series, no compound produced complete inhibition of parasite growth: 6085% of the oocyst population was viable after 180 min exposure at 100 µg/mL. SMAP-29 exerted the highest activity against both sporozoites and oocysts.
Keywords: cathelicidins, Cryptosporidium parvum, susceptibility
* Correspondence address. Clinica Malattie Infettive, c/o Ospedale Regionale, Via Conca, I-60020 Ancona, Italy. Tel: +39-071-596-3715; Fax: +39-071-596-3468; E-mail: anconacmi{at}interfree.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Tomasinsig, C. Pizzirani, B. Skerlavaj, P. Pellegatti, S. Gulinelli, A. Tossi, F. D. Virgilio, and M. Zanetti The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner J. Biol. Chem., November 7, 2008; 283(45): 30471 - 30481. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Klein, O. Cirioni, A. Giacometti, and G. Scalise In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum J. Antimicrob. Chemother., November 1, 2008; 62(5): 1101 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Takeuchi, V. C. Jones, M. Kobayashi, and F. Suzuki Cooperative Role of Macrophages and Neutrophils in Host Antiprotozoan Resistance in Mice Acutely Infected with Cryptosporidium parvum Infect. Immun., August 1, 2008; 76(8): 3657 - 3663. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tomasinsig, B. Skerlavaj, N. Papo, B. Giabbai, Y. Shai, and M. Zanetti Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells J. Biol. Chem., January 6, 2006; 281(1): 383 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Zaalouk, M. Bajaj-Elliott, J. T. George, and V. McDonald Differential Regulation of {beta}-Defensin Gene Expression during Cryptosporidium parvum Infection Infect. Immun., May 1, 2004; 72(5): 2772 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giacometti, O. Cirioni, R. Ghiselli, F. Mocchegiani, G. D'Amato, R. Circo, F. Orlando, B. Skerlavaj, C. Silvestri, V. Saba, et al. Cathelicidin Peptide Sheep Myeloid Antimicrobial Peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 187 - 194. [Abstract] [Full Text] [PDF] |
||||



